New DMSO combo therapy targets stubborn tinnitus in long-COVID patients
NCT ID NCT07567274
First seen May 08, 2026 · Last updated May 23, 2026 · Updated 3 times
Summary
This study tests a special DMSO-based ear drop and skin cream for adults with bothersome tinnitus that started or worsened after long-COVID or a COVID-19 vaccine. Twenty participants will use both treatments for 30 days. The main goal is to see if at least half of them get a 50% or greater improvement in their tinnitus symptoms. Follow-up lasts 12 months via telemedicine.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TINNITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Nationwide Telemedicine Study (Leading Edge Clinic)
Ithaca, New York, 14851, United States
Conditions
Explore the condition pages connected to this study.